nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—Fatigability—Hydrochlorothiazide—nephrolithiasis	0.0782	0.135	CcSEcCtD
Risperidone—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.0225	0.0387	CcSEcCtD
Risperidone—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0176	CcSEcCtD
Risperidone—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0096	0.0165	CcSEcCtD
Risperidone—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0096	0.0165	CcSEcCtD
Risperidone—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0154	CcSEcCtD
Risperidone—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0084	0.0145	CcSEcCtD
Risperidone—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0133	CcSEcCtD
Risperidone—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00684	0.0118	CcSEcCtD
Risperidone—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00653	0.0113	CcSEcCtD
Risperidone—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00636	0.011	CcSEcCtD
Risperidone—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00615	0.0106	CcSEcCtD
Risperidone—HTR2A—urine—nephrolithiasis	0.00594	0.0626	CbGeAlD
Risperidone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00581	0.01	CcSEcCtD
Risperidone—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00986	CcSEcCtD
Risperidone—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00568	0.00979	CcSEcCtD
Risperidone—CYP3A4—urine—nephrolithiasis	0.00549	0.058	CbGeAlD
Risperidone—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00936	CcSEcCtD
Risperidone—CYP2D6—urine—nephrolithiasis	0.00541	0.0571	CbGeAlD
Risperidone—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00917	CcSEcCtD
Risperidone—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00904	CcSEcCtD
Risperidone—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00898	CcSEcCtD
Risperidone—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00508	0.00874	CcSEcCtD
Risperidone—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00498	0.00858	CcSEcCtD
Risperidone—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00847	CcSEcCtD
Risperidone—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00826	CcSEcCtD
Risperidone—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00826	CcSEcCtD
Risperidone—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00821	CcSEcCtD
Risperidone—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00476	0.0502	CbGeAlD
Risperidone—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00811	CcSEcCtD
Risperidone—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00788	CcSEcCtD
Risperidone—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00741	CcSEcCtD
Risperidone—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00733	CcSEcCtD
Risperidone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00722	CcSEcCtD
Risperidone—H1F0—nephron tubule—nephrolithiasis	0.00415	0.0438	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00407	0.043	CbGeAlD
Risperidone—ADRA1B—renal system—nephrolithiasis	0.004	0.0422	CbGeAlD
Risperidone—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00395	0.0068	CcSEcCtD
Risperidone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00677	CcSEcCtD
Risperidone—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00671	CcSEcCtD
Risperidone—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00671	CcSEcCtD
Risperidone—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00667	CcSEcCtD
Risperidone—ADRA1B—kidney—nephrolithiasis	0.00387	0.0408	CbGeAlD
Risperidone—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00664	CcSEcCtD
Risperidone—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00658	CcSEcCtD
Risperidone—H1F0—renal system—nephrolithiasis	0.00377	0.0398	CbGeAlD
Risperidone—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00646	CcSEcCtD
Risperidone—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00635	CcSEcCtD
Risperidone—H1F0—kidney—nephrolithiasis	0.00365	0.0385	CbGeAlD
Risperidone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00627	CcSEcCtD
Risperidone—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00621	CcSEcCtD
Risperidone—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00619	CcSEcCtD
Risperidone—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00619	CcSEcCtD
Risperidone—H1F0—cortex of kidney—nephrolithiasis	0.00355	0.0375	CbGeAlD
Risperidone—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00611	CcSEcCtD
Risperidone—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00606	CcSEcCtD
Risperidone—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00591	CcSEcCtD
Risperidone—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00589	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00589	CcSEcCtD
Risperidone—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00584	CcSEcCtD
Risperidone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0058	CcSEcCtD
Risperidone—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00337	0.0058	CcSEcCtD
Risperidone—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00568	CcSEcCtD
Risperidone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00558	CcSEcCtD
Risperidone—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00321	0.00554	CcSEcCtD
Risperidone—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00313	0.0054	CcSEcCtD
Risperidone—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00538	CcSEcCtD
Risperidone—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00538	CcSEcCtD
Risperidone—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00536	CcSEcCtD
Risperidone—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00532	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0053	CcSEcCtD
Risperidone—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00521	CcSEcCtD
Risperidone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00519	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00519	CcSEcCtD
Risperidone—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00512	CcSEcCtD
Risperidone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00509	CcSEcCtD
Risperidone—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00509	CcSEcCtD
Risperidone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00499	CcSEcCtD
Risperidone—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00288	0.00496	CcSEcCtD
Risperidone—HTR1D—kidney—nephrolithiasis	0.00283	0.0298	CbGeAlD
Risperidone—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00476	CcSEcCtD
Risperidone—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00476	CcSEcCtD
Risperidone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00473	CcSEcCtD
Risperidone—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00273	0.0047	CcSEcCtD
Risperidone—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00469	CcSEcCtD
Risperidone—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00465	CcSEcCtD
Risperidone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00463	CcSEcCtD
Risperidone—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00459	CcSEcCtD
Risperidone—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00456	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00261	0.0045	CcSEcCtD
Risperidone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00447	CcSEcCtD
Risperidone—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00446	CcSEcCtD
Risperidone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00445	CcSEcCtD
Risperidone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00445	CcSEcCtD
Risperidone—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00442	CcSEcCtD
Risperidone—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00441	CcSEcCtD
Risperidone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00441	CcSEcCtD
Risperidone—HTR2B—cortex of kidney—nephrolithiasis	0.00256	0.027	CbGeAlD
Risperidone—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00435	CcSEcCtD
Risperidone—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00251	0.00433	CcSEcCtD
Risperidone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00428	CcSEcCtD
Risperidone—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00426	CcSEcCtD
Risperidone—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00423	CcSEcCtD
Risperidone—HTR1A—renal system—nephrolithiasis	0.00244	0.0257	CbGeAlD
Risperidone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00415	CcSEcCtD
Risperidone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00408	CcSEcCtD
Risperidone—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00407	CcSEcCtD
Risperidone—ADRA2C—nephron tubule—nephrolithiasis	0.00235	0.0248	CbGeAlD
Risperidone—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00405	CcSEcCtD
Risperidone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00235	0.00404	CcSEcCtD
Risperidone—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00401	CcSEcCtD
Risperidone—HTR7—renal system—nephrolithiasis	0.00233	0.0246	CbGeAlD
Risperidone—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00393	CcSEcCtD
Risperidone—HTR7—kidney—nephrolithiasis	0.00225	0.0238	CbGeAlD
Risperidone—ADRA1A—renal system—nephrolithiasis	0.00225	0.0237	CbGeAlD
Risperidone—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00224	0.00385	CcSEcCtD
Risperidone—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0038	CcSEcCtD
Risperidone—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00378	CcSEcCtD
Risperidone—KCNH2—renal system—nephrolithiasis	0.00217	0.0229	CbGeAlD
Risperidone—ADRA2C—renal system—nephrolithiasis	0.00214	0.0226	CbGeAlD
Risperidone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00364	CcSEcCtD
Risperidone—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00209	0.0036	CcSEcCtD
Risperidone—ADRA2C—kidney—nephrolithiasis	0.00207	0.0218	CbGeAlD
Risperidone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00355	CcSEcCtD
Risperidone—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00349	CcSEcCtD
Risperidone—Tension—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00348	CcSEcCtD
Risperidone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00347	CcSEcCtD
Risperidone—ADRA2C—cortex of kidney—nephrolithiasis	0.00202	0.0213	CbGeAlD
Risperidone—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.002	0.00344	CcSEcCtD
Risperidone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00343	CcSEcCtD
Risperidone—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00341	CcSEcCtD
Risperidone—CYP3A5—nephron tubule—nephrolithiasis	0.00197	0.0208	CbGeAlD
Risperidone—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00334	CcSEcCtD
Risperidone—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00332	CcSEcCtD
Risperidone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00329	CcSEcCtD
Risperidone—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00328	CcSEcCtD
Risperidone—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00326	CcSEcCtD
Risperidone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00324	CcSEcCtD
Risperidone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00186	0.0032	CcSEcCtD
Risperidone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00319	CcSEcCtD
Risperidone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00318	CcSEcCtD
Risperidone—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00317	CcSEcCtD
Risperidone—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00313	CcSEcCtD
Risperidone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00312	CcSEcCtD
Risperidone—Cough—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00309	CcSEcCtD
Risperidone—CYP3A5—renal system—nephrolithiasis	0.00179	0.0189	CbGeAlD
Risperidone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00302	CcSEcCtD
Risperidone—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00302	CcSEcCtD
Risperidone—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00302	CcSEcCtD
Risperidone—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00301	CcSEcCtD
Risperidone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00298	CcSEcCtD
Risperidone—CYP3A5—kidney—nephrolithiasis	0.00173	0.0183	CbGeAlD
Risperidone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00295	CcSEcCtD
Risperidone—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00292	CcSEcCtD
Risperidone—CYP3A5—cortex of kidney—nephrolithiasis	0.00169	0.0178	CbGeAlD
Risperidone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00289	CcSEcCtD
Risperidone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00289	CcSEcCtD
Risperidone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00285	CcSEcCtD
Risperidone—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00165	0.00283	CcSEcCtD
Risperidone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00282	CcSEcCtD
Risperidone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0028	CcSEcCtD
Risperidone—ADRA2A—cortex of kidney—nephrolithiasis	0.00161	0.017	CbGeAlD
Risperidone—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00276	CcSEcCtD
Risperidone—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00157	0.0027	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00264	CcSEcCtD
Risperidone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00262	CcSEcCtD
Risperidone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00151	0.0026	CcSEcCtD
Risperidone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00258	CcSEcCtD
Risperidone—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00257	CcSEcCtD
Risperidone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00255	CcSEcCtD
Risperidone—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00252	CcSEcCtD
Risperidone—HTR2A—renal system—nephrolithiasis	0.00145	0.0153	CbGeAlD
Risperidone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00145	0.0025	CcSEcCtD
Risperidone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00247	CcSEcCtD
Risperidone—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00247	CcSEcCtD
Risperidone—HTR2A—kidney—nephrolithiasis	0.0014	0.0148	CbGeAlD
Risperidone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00138	0.00238	CcSEcCtD
Risperidone—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00237	CcSEcCtD
Risperidone—CYP3A4—renal system—nephrolithiasis	0.00134	0.0142	CbGeAlD
Risperidone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0023	CcSEcCtD
Risperidone—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00229	CcSEcCtD
Risperidone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00229	CcSEcCtD
Risperidone—CYP2D6—renal system—nephrolithiasis	0.00132	0.014	CbGeAlD
Risperidone—CYP3A4—kidney—nephrolithiasis	0.0013	0.0137	CbGeAlD
Risperidone—CYP2D6—kidney—nephrolithiasis	0.00128	0.0135	CbGeAlD
Risperidone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00213	CcSEcCtD
Risperidone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00121	0.00208	CcSEcCtD
Risperidone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00205	CcSEcCtD
Risperidone—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00115	0.00198	CcSEcCtD
Risperidone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00191	CcSEcCtD
Risperidone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00184	CcSEcCtD
Risperidone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00182	CcSEcCtD
Risperidone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00182	CcSEcCtD
Risperidone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00181	CcSEcCtD
Risperidone—ABCB1—nephron tubule—nephrolithiasis	0.00105	0.011	CbGeAlD
Risperidone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000998	0.00172	CcSEcCtD
Risperidone—ABCB1—renal system—nephrolithiasis	0.000952	0.01	CbGeAlD
Risperidone—ABCB1—kidney—nephrolithiasis	0.00092	0.00971	CbGeAlD
Risperidone—ABCB1—cortex of kidney—nephrolithiasis	0.000896	0.00946	CbGeAlD
Risperidone—DRD4—Signaling Pathways—RGS14—nephrolithiasis	0.000371	0.00114	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000365	0.00113	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000364	0.00112	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000363	0.00112	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000361	0.00111	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000359	0.00111	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.000358	0.0011	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.000354	0.00109	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000353	0.00109	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00035	0.00108	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.00035	0.00108	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.00035	0.00108	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000344	0.00106	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000343	0.00106	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000342	0.00105	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00034	0.00105	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000337	0.00104	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000337	0.00104	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000336	0.00103	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000334	0.00103	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000332	0.00102	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000332	0.00102	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.000329	0.00101	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000328	0.00101	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000327	0.00101	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000326	0.00101	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000325	0.001	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000325	0.001	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—PTH—nephrolithiasis	0.000322	0.000993	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000322	0.000992	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000321	0.00099	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.00032	0.000987	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—CHRM3—nephrolithiasis	0.00032	0.000986	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000318	0.00098	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000318	0.000978	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000317	0.000977	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000314	0.000966	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000312	0.000963	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000312	0.000962	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000311	0.00096	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000311	0.000959	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—PTH—nephrolithiasis	0.000309	0.000951	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000306	0.000944	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000306	0.000942	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000305	0.000939	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000304	0.000936	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000302	0.00093	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000302	0.00093	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0003	0.000923	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000297	0.000916	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000296	0.000913	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000296	0.000912	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000295	0.000908	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—PTH—nephrolithiasis	0.000293	0.000902	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000293	0.000901	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000292	0.000898	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.000291	0.000896	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000291	0.000896	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000288	0.000887	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000287	0.000884	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000285	0.000879	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000285	0.000879	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000285	0.000877	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000284	0.000875	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000283	0.000873	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.000283	0.000871	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—PTH—nephrolithiasis	0.00028	0.000863	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000278	0.000856	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.000278	0.000855	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000278	0.000855	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000276	0.00085	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.000274	0.000845	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000273	0.000842	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000272	0.000839	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000271	0.000834	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00027	0.000831	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000269	0.000829	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000269	0.000829	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.000268	0.000824	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000265	0.000817	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000262	0.000806	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DGKH—nephrolithiasis	0.000262	0.000806	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000261	0.000805	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00026	0.000801	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00026	0.000801	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.00026	0.000801	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000259	0.000798	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000259	0.000798	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000258	0.000794	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000254	0.000784	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000254	0.000784	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000253	0.000779	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.000252	0.000777	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000252	0.000776	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000252	0.000775	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000252	0.000775	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00025	0.000771	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DGKH—nephrolithiasis	0.00025	0.000771	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.000249	0.000767	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000249	0.000766	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.000248	0.000764	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000248	0.000762	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.000247	0.000762	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000247	0.000761	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000246	0.000757	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000243	0.000748	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00024	0.000741	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.000239	0.000736	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000239	0.000736	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000239	0.000736	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000238	0.000732	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000237	0.000731	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000236	0.000727	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000231	0.000712	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.00023	0.000707	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000229	0.000707	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000228	0.000701	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000226	0.000696	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000226	0.000695	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000226	0.000695	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000225	0.000694	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000225	0.000694	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000225	0.000694	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000225	0.000692	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000222	0.000685	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.000222	0.000685	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000221	0.000681	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.00022	0.000679	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000217	0.000668	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.000216	0.000665	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000215	0.000662	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.00021	0.000647	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.00021	0.000646	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000208	0.000642	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000207	0.000637	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000206	0.000636	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.000206	0.000634	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000205	0.000633	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000205	0.000631	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000204	0.00063	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000204	0.00063	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000204	0.00063	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000202	0.000623	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000201	0.000619	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000201	0.000619	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000201	0.000618	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000194	0.000597	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000194	0.000597	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000193	0.000594	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000193	0.000594	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00019	0.000587	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	0.000189	0.000583	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000188	0.000579	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000188	0.000578	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000188	0.000578	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.000188	0.000578	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.000187	0.000577	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000187	0.000577	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000187	0.000577	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.000187	0.000576	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000187	0.000575	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000186	0.000574	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000185	0.000569	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000185	0.000569	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000185	0.000569	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000184	0.000567	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000184	0.000565	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	0.000181	0.000558	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000179	0.000552	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000176	0.000541	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PTH—nephrolithiasis	0.000173	0.000533	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000173	0.000532	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000172	0.000529	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000171	0.000525	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00017	0.000524	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.00017	0.000524	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.000168	0.000518	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000167	0.000516	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000167	0.000516	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000167	0.000515	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.000167	0.000515	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000167	0.000514	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000166	0.000512	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PTH—nephrolithiasis	0.000166	0.00051	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000164	0.000505	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000164	0.000505	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000163	0.000502	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000162	0.0005	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.000161	0.000495	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.000158	0.000487	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000157	0.000483	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000152	0.000469	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000152	0.000469	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.000149	0.000459	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000147	0.000453	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000146	0.000449	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000145	0.000447	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—APRT—nephrolithiasis	0.000141	0.000435	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000141	0.000435	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00014	0.000432	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000139	0.000429	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000136	0.000418	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000133	0.000411	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000133	0.000411	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000133	0.00041	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000133	0.00041	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.000133	0.000409	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000132	0.000406	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000128	0.000395	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000128	0.000393	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.000124	0.000382	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000123	0.000379	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000122	0.000376	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000121	0.000373	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.000121	0.000372	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000121	0.000372	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000119	0.000365	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000115	0.000354	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000113	0.000347	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000111	0.000341	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.00011	0.00034	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.00011	0.000339	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000108	0.000334	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000102	0.000316	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000101	0.00031	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000101	0.00031	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—AQP1—nephrolithiasis	9.49e-05	0.000292	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CHRM3—nephrolithiasis	9.11e-05	0.000281	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	8.71e-05	0.000268	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—APRT—nephrolithiasis	8.71e-05	0.000268	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—SPP1—nephrolithiasis	8.68e-05	0.000267	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	8.63e-05	0.000266	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CHRM3—nephrolithiasis	8.58e-05	0.000264	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	8.45e-05	0.00026	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—SPP1—nephrolithiasis	8.31e-05	0.000256	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	7.93e-05	0.000244	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—SPP1—nephrolithiasis	7.48e-05	0.000231	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—SPP1—nephrolithiasis	7.38e-05	0.000227	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	6.67e-05	0.000205	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	6.43e-05	0.000198	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	6.4e-05	0.000197	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	6.23e-05	0.000192	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—AQP1—nephrolithiasis	6.21e-05	0.000191	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	6.13e-05	0.000189	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—SPP1—nephrolithiasis	5.65e-05	0.000174	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CHRM3—nephrolithiasis	5.61e-05	0.000173	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	5.56e-05	0.000171	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—SPP1—nephrolithiasis	5.55e-05	0.000171	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	5.44e-05	0.000168	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	5.06e-05	0.000156	CbGpPWpGaD
